Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kimberly B. Dahlman
A Phase I Trial Investigating Pulsatile Erlotinib in Combination With Gemcitabine and Oxaliplatin in Advanced Biliary Tract Cancers
Investigational New Drugs
Oncology
Pharmacology
Related publications
Binimetinib Plus Gemcitabine and Cisplatin Phase I/Ii Trial in Patients With Advanced Biliary Cancers
Clinical Cancer Research
Cancer Research
Oncology
A Phase II Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Biliary Tract Cancers
Clinical Colorectal Cancer
Oncology
Gastroenterology
A Phase II Trial of Fixed-Dose Rate Gemcitabine Plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients
Oncology
Medicine
Cancer Research
Oncology
Biweekly Cisplatin and Gemcitabine in Patients With Advanced Biliary Tract Cancer
International Journal of Cancer
Cancer Research
Oncology
A Case of Advanced Biliary Tract Cancer Successfully Treated With Single-Agent Gemcitabine Chemotherapy in Combination With Juzentaihoto
Kampo Medicine
Gemcitabine and Oxaliplatin (GEMOX) in Gemcitabine Refractory Advanced Pancreatic Adenocarcinoma: A Phase II Study
British Journal of Cancer
Cancer Research
Oncology
Age-Stratified Phase I Trial of a Combination of Bortezomib, Gemcitabine, and Liposomal Doxorubicin in Patients With Advanced Malignancies
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Phase I Clinical Trial of Multiple-Peptide Vaccination for Patients With Advanced Biliary Tract Cancer
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
A Phase I Clinical Trial of Vaccination With KIF20A-derived Peptide in Combination With Gemcitabine for Patients With Advanced Pancreatic Cancer
Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer Research
Allergy
Immunology
Pharmacology